Anil Kumar Shivprasad Tiwari

Title: **Anil Kumar Shivprasad Tiwari: Innovator in Pharmaceutical Solutions**

Introduction

Anil Kumar Shivprasad Tiwari, hailing from Gujarat, India, is a noteworthy inventor in the pharmaceutical domain. With a robust background in chemistry and a passion for innovation, he has made significant contributions to the development of new therapeutic solutions. His groundbreaking work has resulted in a patent that is poised to impact the treatment of psoriatic arthritis.

Latest Patents

Anil Kumar Tiwari holds a patent for an **amorphous form of apremilast**. This innovative formulation presents a novel approach to treating active psoriatic arthritis. The invention not only provides an amorphous version of apremilast but also outlines the process for its preparation. Additionally, it includes a pharmaceutical composition that incorporates amorphous apremilast along with pharmaceutically acceptable carriers, excipients, or diluents.

Career Highlights

Currently, Anil is associated with Cadila Healthcare Limited, a prominent name in the pharmaceutical industry. His dedication to improving pharmaceutical formulations has helped the company advance its mission to provide effective health solutions. Anil's patent showcases his innovative approach to drug formulation, which has the potential to enhance patient outcomes in the treatment of chronic conditions.

Collaborations

Throughout his career, Anil Kumar Tiwari has collaborated with esteemed colleagues, including Brij Khera and Kumar Kamlesh Singh. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of excellence in pharmaceutical innovation.

Conclusion

In conclusion, Anil Kumar Shivprasad Tiwari exemplifies the spirit of innovation within the pharmaceutical industry. His patent for the amorphous form of apremilast signifies a valuable contribution to the treatment of psoriatic arthritis. As he continues to work with Cadila Healthcare Limited, Tiwari remains a promising figure in advancing pharmaceutical sciences and improving patient care.